- Oops!Something went wrong.Please try again later.
Shares of Snap-on Inc. SNA gained more than 8% in the premarket trading session on Oct 22, following solid third-quarter 2020 results. Further, both top and bottom lines increased year over year. Despite the tough COVID-19 environment, the company retained its positive sales momentum during the quarter. Also, gains from the Snap-on Value Creation model contributed to quarterly growth.
Q3 in Details
Snap-on’s adjusted earnings of $3.28 per share in third-quarter 2020 surpassed the Zacks Consensus Estimate of $2.16. Moreover, the figure was up 11% from the year-ago quarter’s adjusted earnings of $2.96 per share.
Net sales grew 4.4% to $941.6 million and beat the Zacks Consensus Estimate of $804 million. The uptick can be attributed to organic sales growth of 3.8%, a $4.2-million positive impact from foreign currency translations and $1 million in contributions from acquisitions.
Adjusted gross profit came in at $469.5 million, up 4.8% year over year, while gross margin advanced 20 bps to 49.9% in the reported quarter.
Further, the company’s adjusted operating earnings before financial services totaled $185.7 million, up 10.7% year over year. Additionally, adjusted operating earnings margin expanded 900 bps to 19.7% in the quarter under review.
Sales in Commercial & Industrial Group fell 8% from the prior-year quarter to $308.4 million due to an organic sales decline of 8.6%, offset by a positive impact of $2.2 million from foreign currency. Sales decline in critical industries and in the Asia-Pacific region hurt the segment to some extent.
The Tools Group segment’s sales rose 16.8% year over year to $449.8 million, driven by organic sales growth of 16.2% and a $1.8-million positive impact of foreign currency. Solid sales performance in the United States and the international franchise operations aided organic sales.
Sales in Repair Systems & Information Group fell 1.6% year over year to $317.5 million. Moreover, organic sales in the segment dropped 2.2% from the year-ago quarter due to lower sales to OEM dealerships, somewhat offset by robust sales in diagnostics and repair information products to independent repair shop owners and managers. However, sales of $1 million from buyouts and $0.8 million related to favorable currency aided growth.
Nevertheless, the Financial Services business reported revenues of $65.6 million, down from $85.8 million in the year-ago quarter.
SnapOn Incorporated Price, Consensus and EPS Surprise
SnapOn Incorporated price-consensus-eps-surprise-chart | SnapOn Incorporated Quote
During the quarter, Snap-on’s cash and cash equivalents totaled $787.5 million compared with $184.5 million as of Dec 28, 2019.
As the world continues to adjust with the changing economic landscape, Snap-on has been witnessing improving trends in the third quarter on a sequential basis. this Zacks Rank #5 (Strong Sell) company remains focused on leveraging its capabilities in the automotive repair space and expanding the base in automotive repair and across regions, particularly critical industries.
Driven by such well-chalked initiatives, management foresees capital expenditure to be $75-$85 million in 2020. Out of this, $39.1 million have already been incurred in the first nine months of 2020. Apart from these, it is on track with the Rapid Continuous Improvement (RCI) plan and cost-cutting actions to combat the ongoing crisis.
In the past three months, shares of the company have gained 9.1% compared with the industry's 13% growth.
Stocks to Consider
Whirlpool Corporation WHR has a long-term earnings growth rate of 16.7%. Currently, it carries a Zacks Rank #1. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Crocs’ CROX bottom line beat estimates by 191.8%, on average, over the trailing four quarters. It also carries a Zacks Rank #2.
Electrolux AB ELUXY has an impressive long-term earnings growth rate of 7.9% and a Zacks Rank #2.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Whirlpool Corporation (WHR) : Free Stock Analysis Report
SnapOn Incorporated (SNA) : Free Stock Analysis Report
Electrolux AB (ELUXY) : Free Stock Analysis Report
Crocs, Inc. (CROX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research